Aviance Capital Partners’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Buy
4,992
+68
+1% +$5.21K 0.04% 295
2026
Q1
$398K Sell
4,924
-190
-4% -$15.8K 0.05% 268
2025
Q4
$391K Sell
5,114
-521
-9% -$40K 0.05% 268
2025
Q3
$448K Buy
5,635
+410
+8% +$30.7K 0.05% 255
2025
Q2
$366K Buy
5,225
+189
+4% +$13.8K 0.05% 262
2025
Q1
$372K Buy
5,036
+706
+16% +$49.8K 0.05% 249
2024
Q4
$300K Buy
4,330
+542
+14% +$41.2K 0.04% 263
2024
Q3
$318K Buy
3,788
+221
+6% +$17K 0.04% 266
2024
Q2
$242K Buy
+3,567
New +$229K 0.03% 290

Other funds holding NHI

Aviance Capital Partners's NHI Position: Q2 2026 in Review

Aviance Capital Partners increased its National Health Investors (NHI) stake by 1.4% in Q2 2026, buying an estimated $5.21K and bringing the position to 4,992 shares worth $381K. The position accounts for 0.04% of the portfolio, ranked #295.

Aviance Capital Partners first reported a position in NHI in Q2 2024 and has held it in 9 quarters since. The position peaked at $448K in Q3 2025. 303 funds tracked by Wall St. Rank hold NHI as of Q2 2026.

  • Aviance Capital Partners held 4,992 shares of National Health Investors worth $381K as of Q2 2026.
  • Aviance Capital Partners bought 68 National Health Investors shares in Q2 2026, an estimated $5.21K.
  • National Health Investors made up 0.04% of Aviance Capital Partners's portfolio in Q2 2026, its #295 holding.
  • Aviance Capital Partners first reported a position in National Health Investors in Q2 2024 and has held it in 9 quarters since.
  • Aviance Capital Partners's National Health Investors position peaked at $448K in Q3 2025.
  • 303 funds tracked by Wall St. Rank held National Health Investors as of Q2 2026.

Based on Aviance Capital Partners's 13F filing for Q2 2026, filed 31 Jul 2026.